Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
0.003750 USD | +7.14% | +2.70% | -52.50% |
Financials (USD)
Sales 2022 | 50,000 | Sales 2023 * | - | Capitalization | 4.47 M |
---|---|---|---|---|---|
Net income 2022 | -2.00 M | Net income 2023 * | - | EV / Sales 2022 | 88,2x |
Net cash position 2022 | 65,000 | Net cash position 2023 * | - | EV / Sales 2023 * | - |
P/E ratio 2022 | -1,64x | P/E ratio 2023 * | Employees | - | |
Yield 2022 | - | Yield 2023 * |
-
| Free-Float | 81.34% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | +7.14% | ||
1 week | +2.70% | ||
Current month | +8.57% | ||
1 month | -13.64% | ||
3 months | -5.00% | ||
6 months | -11.63% | ||
Current year | -52.50% |
1 week
0.00
0.00

1 month
0.00
0.00

Current year
0.00
0.01

1 year
0.00
0.01

3 years
0.00
0.05

5 years
0.00
0.05

10 years
0.00
0.18

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | 2007 | |
Marvin Maslow
FOU | Founder | 86 | 1992 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marvin Maslow
FOU | Founder | 86 | 1992 |
Director/Board Member | 73 | 2007 | |
Chief Executive Officer | 71 | 2007 |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 0.003750 | +7.14% | 13,400 |
23-11-29 | 0.003500 | 0.00% | 30,225 |
23-11-28 | 0.003500 | -6.67% | 12,100 |
23-11-27 | 0.003750 | +2.74% | 275 |
Delayed Quote OTC Markets, December 01, 2023 at 03:15 pm EST
More quotes
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. The Company's business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate, and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
1st Jan change | Capi. | |
---|---|---|
-52.50% | 2 M $ | |
+65.53% | 40 132 M $ | |
+5.87% | 39 586 M $ | |
-55.56% | 30 438 M $ | |
-26.11% | 28 571 M $ | |
+38.66% | 22 175 M $ | |
-27.87% | 21 511 M $ | |
+1.62% | 17 412 M $ | |
-13.43% | 11 313 M $ | |
-7.44% | 10 346 M $ |